Tillots Pharma licenses CHO cell line tech from Lonza and BioWa
Lonza and BioWa’s POTELLIGENT CHOK1SV technology will be licensed by Tillots Pharma to develop its antibody pipeline.
Archives for March 23, 2018
Abzena strikes deal to access cell lines
Abzena has gained access to a major mammalian cell line depository it says will cut license negotiations for its customers.
Nohla signs WuXi AppTec to make cell therapies for bone marrow function
Nohla Therapeutics has selected WuXi AppTec Advanced Therapies to make its lead candidate, indicated to treat patients with hematologic malignances.